ABOUT US

Our Milestones

We are always moving forward at New Equilibrium Biosciences.
June 2021
Title

New Equilibrium received Servier Spark Award from Servier and LabCentral.

June 2021
May 2021
Title

Leia Jekel joined New Equilibrium as a Data Analysis and Communications intern.

May 2021
May 2021
Title

Austin Alexander joined New Equilibrium as an Operations Manager.

May 2021
April 2021
Title

Lars Bratholm joined New Equilibrium as a Machine Learning Scientist.

April 2021
December 2020
Title

David Hill joined New Equilibrium as an Executive Assistant.

December 2020
October 2020
Title

New Equilibrium moved into LabCentral in Cambridge.

October 2020
September 2020
Title

New Equilibrium received SBIR Phase I grant from NSF to productize their platform.

September 2020
September 2020
Title

Mahdieh Yazdani joined New Equilibrium as a Data Science & Advanced Analytics Intern. Thanks for all the support, MLSC!

September 2020
September 2020
Title

New Equilibrium graduated from MassCONNECT.DH mentorship program. Our sincerest thanks to all of our mentors!

September 2020
September 2020
Title

UMass Voucher (NMR): Thanks for all the support, Massachusetts!

September 2020
June 2020
Title

Darren Dsouza and Hang Cao joined New Equilibrium as summer interns!

June 2020
June 2020
Title

Rangsiman left for graduate school at the University of Zurich. Good luck Rangsiman!

June 2020
June 2020
Title

New Equilibrium began MassCONNECT.DH mentorship program.

June 2020
May 2020
Title

Dr. Charles DeLisle joined New Equilibrium as an experimental biophysicist.

May 2020
May 2020
Title

New Equilibrium received MassNextGen grant from MLSC.

May 2020
April 2020
Title

UMass Voucher (CM): Dr. Chungwen Liang joined New Equilibrium as a modeling consultant.

April 2020
November 2019
Title

Rangsiman Ketkaew joined New Equilibrium as a QM/AWS Consultant.

November 2019
October 2019
Title

New Equilibrium joined the Petri accelerator.

October 2019
October 2019
Title

Virginia Burger and Peter Tompa incorporated New Equilibrium.

October 2019
July 2019
Title

Virginia Burger and Peter Tompa decided to form a drug discovery company focused on targeting intrinsically disordered proteins in cancers and neurodegenerative disorders.

July 2019